Search

everythinglearnresearchcommunity

for

Search:↓

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Diet changes can help reduce acne by limiting certain hormones.

Hair transplantation techniques have improved over time, leading to natural-looking results and high graft survival rates, making it a popular treatment for hair loss.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Cells that move well may improve hair loss treatments by entering hair follicles.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Lower levels of certain genes in hair cells improve hair loss treatment outcomes.

Extracellular vesicles may effectively treat hair loss with minimal side effects.

Combining microneedling with light therapy increased hair density by 26% in men.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

Analyzing bear poop helps measure their stress without harming them.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

About 15% of US Army personnel use hair products containing hormone or placenta, with higher usage among non-whites, females, and enlisted personnel.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Topical botanical lotion increases hair density and improves quality of life in women with hair loss.

The new gel for hair loss is safe, effective, and reduces side effects.

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.